Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Invited discussant LBA1

Date

08 Oct 2016

Session

Presidential Symposium 1

Presenters

Stephen Johnston

Authors

S. Johnston

Author affiliations

Medical Oncology, Royal Marsden Hospital NHS Foundation Trust, London/GB

More

Resources

Reserved to ESMO members

Login Join ESMO

View the presentation

Resources from the same session

08 Oct 2016

Ipilimumab (IPI) vs placebo (PBO) after complete resection of stage III melanoma: final overall survival results from the EORTC 18071 randomized, double-blind, phase 3 trial

Presenter: Alexander Eggermont

Session: Presidential Symposium 1

Resources:

Abstract

Presentation

08 Oct 2016

Invited discussant LBA3

Presenter: Sandro Pignata

Session: Presidential Symposium 1

Resources:

Presentation

08 Oct 2016

Invited discussant LBA2

Presenter: Olivier Michielin

Session: Presidential Symposium 1

Resources:

Presentation

08 Oct 2016

First-line ribociclib + letrozole for postmenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2–), advanced breast cancer (ABC)

Presenter: Gabriel Hortobagyi

Session: Presidential Symposium 1

Resources:

Abstract

Presentation

08 Oct 2016

A randomized, double-blind phase 3 trial of maintenance therapy with niraparib vs placebo in patients with platinum-sensitive recurrent ovarian cancer (ENGOT-OV16/NOVA trial)

Presenter: Mansoor Raza Mirza

Session: Presidential Symposium 1

Resources:

Abstract

Presentation